On August 26, 2010, the DePuy Orthopaedics company, a subsidiary of Johnson & Johnson, issued a voluntary recall of two hip replacement systems. About 93,000 of the devices have been implanted worldwide, according to a DePuy spokesperson.

The hip implants are known as the ASR XL Acetabular System and DePuy ASR Hip Resurfacing System. The chances are that one out of eight of the implants will fail, requiring painful and expensive “revision” surgery.

Too late

The first lawsuit filed in the United States against DePuy over these defective ASR hip implant was in March, 2009 — almost 18 months before the device was recalled. Another lawsuit quoted in this news article states: “Officials of J&J’s DePuy Orthopaedics unit knew for years many of the 93,000 patients with ASR hip implants required corrective surgeries.”

In fact, the Food & Drug Administration had received over 500 complaints about these implants over the past few years

Late in 2009, DePuy announced it was phasing out the implants because of slow sales. But in March, the company warned doctors that the implants might have a high failure rate in some patients. As one doctor said succinctly, “It is way too late.”

So, despite lawsuits beginning nearly a year and a half before, years of complaints to the FDA, and warnings to doctors in March, DePuy waited until the end of August 2010 to issue the recall.

Furthermore, stopping production of the devices more than eight months before the recall has been compared to a “phantom recall,” in which Johnson & Johnson hired contractors to secretly buy back tens of thousands of packets of defective Motrin. That recall and a spate of others were the focus of a congressional hearing September 30, 2010, where federal regulators testified that Johnson & Johnson repeatedly did not investigate and fix problems with its medicines.

Too little

DePuy’s recall notice opened with this sentence: “DePuy makes patient safety and health a top priority and is continually evaluating data about its products.”

But the notice also stated, “DePuy intends to cover reasonable and customary costs of testing and treatment if you need services, including revision surgery if it is necessary, associated with the recall of ASR … DePuy will then reimburse you for your reasonable out-of-pocket expenses.”

If you were implanted with this defective device you are entitled to complete compensation, not just what DePuy decides is “reasonable.” Their offer leaves out injury such as the effect on overall physical and mental health, pain and mental anguish, disfigurement or scarring, and future medical expenses.

Link to this article to learn more about symptoms, injuries, and damages a defective implant can cause. You also may receive documents requesting access to your medical records – which you should not sign.

The severity of the health issues involved and DePuy's limited offer of compensation mean you will need the counsel of an expert hip-replacement attorney. To be sure that you receive justice in your case, call us at Egerton Law – 336-273-0508 1-800-800-4LAW (4529). We will do what it takes to get you a fair and just settlement.

1 Comments
Compensation claims are inevitable from those who will have to undergo revision surgery due to the wear and tear factor leading to inflammation around the hip and groin, the possible loosening or dislocation of the hip implant, and the potential for a hip fracture due to the weaker bone.
by DePuy Claims November 2, 2010 at 02:52 AM
Post a Comment